Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

書目詳細資料
主要作者:	Mirza, Maisa Tasnim
其他作者:	Jamiruddin, Dr. Mohd. Raeed
格式:	Thesis
語言:	English
出版:	Brac University 2023
主題:	Aromatase inhibitors Breast cancer Ductal carcinoma in situ Estrogen receptor positive Hormonal therapy Tamoxifen. Breast > Cancer > Chemoprevention.
在線閱讀:	http://hdl.handle.net/10361/18147

相似書籍

Breast cancer awareness seminars
由: Anwer Khan Modern Medical College
出版: (2016)

Recent advancement on breast cancer detection and treatment
由: Rahman, Sanjida
出版: (2023)

Natural products and their combinatory effects in breast cancer treatment
由: Siddique, Md. Ayman
出版: (2021)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
由: Shobnam, Sohana
出版: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
由: Alam, Kazi Tasnuva
出版: (2022)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
由: Raihan, Dilraj
出版: (2024)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
由: Akter, Honufa
出版: (2024)

Breast cancer in low-resource settings: Prioritizing the awareness and access programmes to overcome sociocultural and economic barriers for early detection and improved outcomes
由: Iqbal, Mohammad Shamim, et al.
出版: (2017)

The impact of breast cancer on women’s lives in Bangladesh
由: Mobashera, Tayeeba Tum
出版: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
由: Chakraborty, Anuradha
出版: (2024)

A review on triple-negative breast cancer and its potential treatment
由: Niasa, Jannatul Ferdous
出版: (2023)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
由: Araf, Faiaz Fahim
出版: (2024)

Machine learning as an indicator for breast cancer prediction
由: Shadman, Tahsin Mohammed, et al.
出版: (2019)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
由: Nuha, Nabiha Tahsin
出版: (2024)

Breast cancer therapy through Liposomal drug delivery system
由: Ome, Nusrat Jahan
出版: (2024)

Pathway analysis of Disease-Gene associated network in the human breast cancer
由: Lamia
出版: (2020)

Early detection of breast cancer using machine learning
由: Fuad, Wasi Mohammad
出版: (2019)

Breast cancer in South Asia: a Bangladeshi perspective
由: Hossain, Mohammad Sorowar, et al.
出版: (2017)

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
由: Parvin, Salma, et al.
出版: (2016)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
由: Oishy, Jannatun Noor
出版: (2024)

Breast cancer prediction using different machine learning models
由: Khandker Al- Muhaimin, et al.
出版: (2020)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
由: Bristy, Israt Zerin
出版: (2021)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
由: Hasan, Sakib
出版: (2024)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
由: Monayem, Kazi Fahim
出版: (2024)

Exploring the use of Ingenol Mebutate to prevent non-melanoma skin cancer: A review
由: Haque, Fariha
出版: (2023)

Machine learning In breast cancer prognosis and prediction
由: Chowdhury, Shah Abul Hasnat, et al.
出版: (2023)

Elucidating the functional roles of bidirectionally transcribed genes in immunobiology of cancers
由: Ahmad, Sheikh Shafin
出版: (2021)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
由: Rahman, Sanjida
出版: (2024)

Statistics and informatics in molecular cancer research

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
由: Karim, Azrin
出版: (2024)

Immunotherapy in the treatment of renal cancer
由: Shimu, Sumaya
出版: (2022)

Effect of passive immunization with mouse Anti-BCG 64 kDa protein on ehrlich ascites carcinoma cells
由: Chowdhury, Maisha Mosharrat
出版: (2018)

Cancer risk factors: a critical review
由: Tabassum, Tahsina
出版: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
由: Nawar, Anika
出版: (2019)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
由: Zangmo, Thinley
出版: (2024)

Application of deep convolutional neural network in breast cancer prediction using Digital Mammograms
由: Al Mamun, Rafsan, et al.
出版: (2022)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
由: Abir, Shifaty Nur
出版: (2024)

Targeting BRAFV600E in the treatment of CRC
由: Roja, Mashwiyat Samrin
出版: (2024)

Role of statins as antagonists of SPARC in gastric cancer
由: Shahmat, Rad
出版: (2019)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
由: Pial, Sazia Afrin
出版: (2018)